Description
Glucovance (glyburide and metformin hydrochloride) is a sulfonylurea listed in our Diabetes combination medications and Type 2 diabetes medications directories and prescribed for type 2 diabetes (1.1) (2.1). Administered via the oral route, Glucovance is available for delivery to U.S. residents through Canadian Pharmacy Store with a valid prescription. Review the clinical fact table, dosage directions, cautions, drug interactions, side effects, and official regulatory sources below.
Glucovance is a medication containing the active pharmaceutical ingredient glyburide and metformin hydrochloride, classified pharmacologically as a sulfonylurea (2.1). It is clinically indicated for the management of type 2 diabetes as part of a comprehensive treatment plan supervised by a licensed healthcare provider (2.1).
Within the Diabetes combination medications section of our catalogue, patients and prescribers frequently review Glucovance alongside related therapies such as Diabeta (Glyburide), Amaryl (Glimepiride), Glimepiride, and Glipizide.
Official Indications and Usage
Glyburide and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1.1)
Mechanism of Action and Pharmacology
Glyburide primarily lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin. Metformin is an antihyperglycemic agent that improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may decrease. (1.1) (1.1)
What is Type 2 diabetes?
Type 2 diabetes involves high blood glucose because the body does not use insulin effectively and may not make enough. Treatment depends on individual glucose, heart, kidney, and other health needs. Explore related medications below and discuss treatment options with your healthcare provider. Read our complete Type 2 diabetes condition guide for appointment questions and related therapies (3.1).
Ordering Glucovance from Canada for U.S. Delivery
U.S. patients can order Glucovance (Glyburide, Metformin) in U.S. dollars with a valid prescription from a U.S.-licensed clinician. Your card is only charged after your prescription passes pharmacist safety checks and is ready to ship.
Step 1
Send Your Prescription
- Valid Rx required from a U.S.-licensed physician, NP, or PA (Rx rules).
- Upload Rx online, request a pharmacy transfer, or have your doctor fax (844) 666 – 6819.
- Order up to a 90-day personal-use supply per shipment (refill planning).
Step 2
Pharmacist Safety Check
- Multi-point dosing and interaction review completed in under 1 business day.
- Mandatory licensed pharmacist consultation via phone, voicemail, or text before dispatch.
- Verified under our Pharmacy Safety Standards.
Step 3
$14.99 USD Tracked Parcel
- Packed in discreet protective packaging for a flat $14.99 USD per order ($29.99 if combined with cold-chain).
- Tracked via Canada Post and USPS: 3 to 7 business days from Canada (7 to 14 days from international partners).
- Review full shipping and delivery details.
Step 4
U.S. Street Delivery & Payment
- Delivered to any physical U.S. street address with signature upon delivery (no P.O. Boxes).
- You see and approve the country of origin upfront before your card is charged.
- Report any delayed or damaged parcel within 48 hours for prompt resolution.
Fact Table
| Clinical Specification | Details |
|---|---|
| Brand / Product Name | Glucovance |
| Chemical / Generic Name | Glyburide And Metformin Hydrochloride |
| Pharmacological Class | Sulfonylurea |
| Therapeutic Category | Type 2 diabetes medications · Diabetes combination medications |
| Same-Ingredient Catalogue Entries | Diabeta (Glyburide) |
| Molecular Formula | C23H28ClN3O5S (2.1) |
| Molecular Weight | 494.0 g/mol (2.1) |
| IUPAC Chemical Name | 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide |
| Bioavailability | ~50% (1.1) |
| Elimination Half-Life | ~10 hours (1.1) |
| Legal Status | Rx-Only (Prescription Required) |
| Regulatory Reference Authorities | U.S. FDA (DailyMed), Health Canada (DPD), NIH PubChem, NLM MedlinePlus |
| Routes of Administration | Oral |
| Dosage Forms & Strengths | Glyburide and metformin hydrochloride tablets, USP are available as: 1.25 mg/250 mg Tablets: Yellow, capsule shaped, biconvex, film-coated tablet with ‘A’ |
| Primary Indications | Type 2 Diabetes |
| Pregnancy & Breastfeeding | Consult Doctor / Prescriber before use |
| PubChem CID | 3488 |
| FDA UNII Identifier | SX6K58TVWC, 786Z46389E |
| NLM RxNorm Concept ID (RxCUI) | 861753 |
| FDA Application License | ANDA077870 |
| Official DailyMed SetID | 4dcef36f-000e-43f5-8d67-0e2a079ab2c6 |
| Catalogue Index Links | Letter G Index · All Medications · All Categories |
Directions
Dosage and Administration Overview
Adult Dosage: Give glyburide and metformin hydrochloride tablets in divided doses, twice daily, with meals. For patients not treated with either glyburide (or another sulfonylurea) or metformin HCl, initiate treatment with another formulation with a dose of 1.25 mg glyburide and 250mg metformin HCl orally, once or twice daily with meals. For patients not adequately controlled on either glyburide (or another sulfonylurea) or metformin HCl alone, the recommended starting dose is 2.5 mg/500 mg or 5 mg/500 mg orally twice daily with meals. For patients previously treated with a combination therapy of glyburide (or another sulfonylurea) and metformin HCl, the starting dose should not exceed the daily dose of glyburide (or equivalent dose of another sulfonylurea) and metformin HCl already being taken. Increase the dose gradually on the basis of glycemic control and tolerability, up to a maximum to a maximum dose of 20 mg glyburide/2000 mg metformin HCl daily. (1.1)
Presentations and Strengths
Glyburide and metformin hydrochloride tablets, USP are available as: 1.25 mg/250 mg Tablets: Yellow, capsule shaped, biconvex, film-coated tablet with ‘A’ debossed on one side and ‘46’ on the other side. 2.5 mg/500 mg Tablets: Light pink, capsule shaped, biconvex, film-coated tablet with ‘A’ debossed on one side and ‘47’ on the other side. (1.1)
Administration Guidance
Take Glucovance orally at the same time(s) each day as directed on your prescription label (1.1). Check with your pharmacist whether your specific formulation should be taken with a meal or on an empty stomach, and swallow extended-release or film-coated tablets whole without crushing, chewing, or splitting unless the tablet is scored and your prescriber has instructed you to do so.
Missed Dose Guidance
If you miss a scheduled dose of Glucovance, follow the missed-dose instructions in the official patient leaflet or ask your pharmacist. Do not double the next dose to make up for a missed dose (2.1).
Ingredients
Active Pharmaceutical Ingredient
The active ingredient in Glucovance is glyburide and metformin hydrochloride (molecular formula C23H28ClN3O5S, molecular weight 494.0 g/mol) (2.1) (2.1). Other catalogue entries containing glyburide include Diabeta (Glyburide).
Inactive Ingredients (Excipients)
According to the U.S. FDA product labeling, formulation excipients include microcrystalline cellulose, croscarmellose sodium, povidone, magnesium stearate, hypromellose, propylene glycol, polysorbate 80, talc, titanium dioxide and FD&C Yellow#6 aluminum lake (1.1). Inactive ingredients can vary slightly between different manufacturers and international or generic presentations; review the dispensed carton if you have known excipient sensitivities.
Cautions and important safety information
Boxed Warning
Warning: lactic acidosis Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (>5 mmol/Liter), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally >5 mcg/mL. (1.1)
Contraindications
Glyburide and metformin hydrochloride tablets are contraindicated in patients with: Severe renal impairment (eGFR below 30 mL/min/1.73 m² ). Hypersensitivity to metformin or glyburide. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Concomitant administration of bosentan. (1.1)
Key Clinical Precautions
Before starting or continuing Glucovance, discuss your complete medical history with your healthcare provider. Key clinical cautions include (1.1):
- Lactic acidosis: A rare but serious metabolic complication that can occur with metformin-containing therapies, particularly in patients with impaired kidney or liver function, severe dehydration, hypoxic states, or excessive alcohol intake. Symptoms include unusual muscle pain, trouble breathing, stomach discomfort, dizziness, or feeling cold.
- Heart failure: Fluid retention or cardiovascular workload changes may precipitate or worsen congestive heart failure in susceptible patients. Report sudden weight gain, shortness of breath, or ankle and leg swelling to your healthcare provider.
- Cardiovascular events: Depending on the medication class and underlying medical history, patients should be monitored for signs of cardiovascular events such as chest pain, shortness of breath, sudden weakness, or slurred speech.
- Hypoglycemia (low blood sugar): When used alongside insulin therapies or insulin secretagogues (such as sulfonylureas), the risk of hypoglycemia increases. Patients may need a lower dose of their secretagogue or insulin and should recognize symptoms like shakiness, sweating, fast heartbeat, dizziness, and confusion.
- Hypotension and volume depletion: Intravascular volume contraction can cause symptomatic low blood pressure, orthostatic dizziness, or fainting, especially in older adults, patients with impaired renal function, or those taking diuretics. Ensure adequate hydration before and during therapy.
Pregnancy, Lactation, and Special Populations
Available data from a small number of published studies and postmarketing experience with glyburide use in pregnancy over decades have not identified any drug associated risks for major birth defects, miscarriage, or adverse maternal outcomes. However, sulfonylureas (including glyburide) cross the placenta and have been associated with neonatal adverse reactions such as hypoglycemia. Therefore, glyburide and metformin hydrochloride should be discontinued at least two weeks before expected delivery. Limited data with metformin in pregnant women are not sufficient to determine a drug-associated risk for major birth defects or miscarriage. (1.1)
Interactions
Official Drug Interaction Overview
And Metformin Hydrochloride Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis. Concomitant use of these drugs with glyburide and metformin hydrochloride may increase the risk for lactic acidosis. Intervention: Consider more frequent monitoring of these patients. Examples: Topiramate, zonisamide, acetazolamide and dichlorphenamide. (1.1)
Important Interaction Categories
Concomitant use of Glucovance with certain prescription medications, over-the-counter drugs, or supplements can alter how the medication works or increase the risk of side effects. Important interaction categories to review with your prescriber and pharmacist include (2.1):
- Nonsteroidal anti-inflammatory drugs (NSAIDs in our Pain and inflammation directory, such as Celebrex (Celecoxib) or Meloxicam): Combining NSAIDs with this medication may reduce renal perfusion, diminish antihypertensive or diuretic efficacy, or increase the risk of gastrointestinal bleeding and acute kidney injury.
- Monoamine oxidase inhibitors (MAOIs, such as phenelzine, tranylcypromine, selegiline, or linezolid): Concomitant use or use within 14 days of stopping an MAOI can cause severe drug interactions, including hypertensive crisis, serotonin syndrome, or enhanced hypoglycemic and central nervous system effects.
- Alcohol: Excessive alcohol consumption can potentiate blood-sugar fluctuations, increase the risk of lactic acidosis or ketoacidosis in metabolic therapies, heighten gastrointestinal irritation, or increase drowsiness and orthostatic dizziness.
Side effects
Like all medications, Glucovance can cause side effects, although not everyone experiences them. Commonly reported side effects in clinical trials and official labeling include (1.1):
- Nausea (feeling sick): Often mild to moderate and most noticeable when starting therapy or increasing the dose; taking oral doses with food (when permitted by the label) may help.
- Vomiting: Persistent vomiting that prevents fluid intake should be reported to your clinician to prevent dehydration.
- Diarrhea (loose stools): Maintain adequate fluid and electrolyte intake; contact your prescriber if diarrhea is severe or persistent.
- Headache: Commonly reported during initial treatment; often improves as your body adjusts to the medication.
- Dizziness or lightheadedness: May occur especially when standing up quickly from a sitting or lying position (orthostatic changes); rise slowly and stay well hydrated.
- Abdominal discomfort or stomach pain: Mild gastrointestinal upset may occur; report severe, persistent, or radiating abdominal pain promptly.
Clinical Trial and Postmarketing Adverse Reactions
The following adverse reactions are also discussed elsewhere in the labeling: Lactic Acidosis Hypoglycemia Cardiovascular mortality Hemolytic anemia Vitamin B 12 Deficiency Most common (>5%) adverse reactions to glyburide and metformin hydrochloride diarrhea, headache, nausea/vomiting, abdominal pain, and dizziness. (1.1)
When to Seek Immediate Medical Attention
Contact your physician or seek urgent medical care if you experience signs of a severe allergic reaction (hives, difficulty breathing, or swelling of the face, lips, tongue, or throat), severe dizziness or fainting, unexplained severe pain, or any sudden change in your clinical symptoms (2.1).
Storage and handling
Glyburide and Metformin Hydrochloride Tablets USP, 5 mg/500 mg: Yellow, capsule shaped, biconvex, film-coated tablet with ‘A’ debossed on one side and ‘48’ on the other side. Dispense in light-resistant containers. Repackaged/Relabeled by: Bryant Ranch Prepack Burbank, CA 91504. (1.1)
Store Glucovance in its original container at controlled room temperature away from excess heat, direct light, and moisture (such as bathroom cabinets), and keep out of reach of children and pets (1.1).
Frequently Asked Questions About Glucovance
What is Glucovance and what active ingredient does it contain?
Glucovance is a sulfonylurea containing the active pharmaceutical ingredient glyburide and metformin hydrochloride (chemical formula C23H28ClN3O5S). It is supplied for oral administration and requires a valid prescription where applicable.
How does Glucovance work in the body?
Glyburide primarily lowers blood glucose by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin. Metformin is an antihyperglycemic agent that improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose.
What conditions is Glucovance prescribed to treat?
Glucovance is primarily indicated for type 2 diabetes. Your prescribing clinician determines the appropriate indication, strength, and treatment duration based on your individual diagnosis and medical history.
How should I take or use Glucovance?
Follow the exact dosage, frequency, and administration instructions printed on your prescription label. Glucovance is administered via the oral route. Take it consistently at the same time(s) as directed, and never adjust your dose or stop therapy without speaking with your prescriber.
What are the most common side effects of Glucovance?
Commonly reported side effects of Glucovance include feeling sick, vomiting, loose stools, headache, dizziness, and abdominal pain. Most mild side effects improve as your body adjusts to treatment, but you should notify your doctor or pharmacist if symptoms persist or worsen.
What medications or substances can interact with Glucovance?
Important interaction categories for Glucovance include nonsteroidal anti-inflammatory medicines, monoamine oxidase inhibitors, and alcohol. Always share a complete list of your prescription drugs, over-the-counter medicines, vitamins, and herbal supplements with your pharmacist before starting treatment.
Can Glucovance be used during pregnancy or breastfeeding?
If you are pregnant, planning to become pregnant, or breastfeeding, consult your prescribing physician before using Glucovance to weigh the clinical benefits and potential risks.
Do I need a prescription to buy Glucovance online from Canada?
Yes. A valid prescription written by a U.S.-licensed physician, nurse practitioner, or physician assistant is required to buy Glucovance (Glyburide, Metformin) through our licensed Canadian pharmacy partners. Valid prescriptions go through multiple safety checks in less than 1 business day, followed by a mandatory request to speak with a licensed pharmacist for a consultation (watch your phone, voicemails, and text messages).
Does Glucovance have a generic equivalent (Glyburide, Metformin) at a Canada pharmacy?
Currently, Glucovance (Glyburide, Metformin) is dispensed in our catalogue as a brand-name formulation. Check our Glyburide, Metformin active ingredient hub for updates as licensed generic presentations become available.
How is Glucovance shipped to U.S. residents, and how much does shipping cost?
Glucovance ships in discreet protective packaging at a flat rate of $14.99 USD per order via Canada Post and USPS with full tracking (if combined in the same order with a cold-chain item, total shipping is $29.99 USD in a larger container). Once your valid prescription passes safety checks (<1 business day) and you respond to the mandatory licensed pharmacist consultation request via phone, voicemail, or text message, delivery takes 3 to 7 business days from Manitoba, Canada (or 7 to 14 business days from licensed partner pharmacies in the UK, Singapore, and Mauritius). You see and choose the country of origin before you pay, and your Visa, Mastercard, or Discover card is only charged when your order is ready to ship.
How can I send or transfer my Glucovance prescription, or ask about an unlisted strength?
You can upload a clear photo or PDF of your Glucovance prescription online, request a prescription transfer or direct prescriber coordination from our team, or have your prescriber fax the prescription directly to (844) 666 – 6819. You may order up to a 90-day personal-use supply per shipment. If you do not see your exact prescribed strength or manufacturer listed, call 1-888-868-1920 and our staff will check availability across our licensed pharmacy partners.
References & Official Sources
Clinical, pharmacological, and safety facts for Glucovance (Glyburide,Metformin) are compiled directly from official regulatory prescribing labels and primary biomedical databases:
- (1.1) Glyburide and Metformin Hydrochloride. U.S. National Library of Medicine / U.S. Food and Drug Administration (DailyMed). Official U.S. FDA / DailyMed Structured Product Labeling (SPL). (Accessed 2026-10-29).
- (2.1) PubChem Compound Summary for cid 3488 (Glyburide). National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine. Official regulatory & clinical reference. (Accessed 2026-10-29).
- (3.1) MedlinePlus Medical Encyclopedia: Diabetes Type 2. MedlinePlus / National Library of Medicine. U.S. National Library of Medicine, MedlinePlus Drug & Health Information. (Accessed 2026-10-29).
- (4.1) Health Canada Drug Product Database (DPD), Authorized Product Records. Health Canada / Government of Canada. Health Canada Drug Product Database & Official Product Monograph. (Accessed 2026-10-29).
